How This Gene Therapy Name Partially Reversed Its Catastrophic 44% Dive

Ultragenyx Pharmaceuticals won approval for its newest gene therapy on Thursday, helping shares partially reverse a catastrophic dive. The post How This Gene Therapy Name Partially Reversed Its Catastrophic 44% Dive appeared first on Investor's Business Daily.